Jiayu Wang Selected Research

Jiayu Wang Research Topics

Disease

70	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2010
59	Neoplasms (Cancer) 05/2024 - 01/2012
29	Triple Negative Breast Neoplasms 11/2023 - 01/2013
17	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2012
10	Inflammation (Inflammations) 03/2024 - 09/2014
9	Disease Progression 12/2023 - 01/2010
6	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2018
5	Neutropenia 01/2022 - 10/2015
4	COVID-19 07/2024 - 03/2021
4	Infections 03/2024 - 01/2011
4	Stomach Neoplasms (Stomach Cancer) 12/2023 - 02/2022
4	Cognitive Dysfunction 05/2023 - 01/2019
4	Emergence Delirium 01/2022 - 01/2020
4	Hypertension (High Blood Pressure) 03/2021 - 05/2015
3	Colitis 03/2024 - 11/2021
3	Carcinoma (Carcinomatosis) 02/2024 - 01/2017
3	Squamous Cell Carcinoma of Head and Neck 12/2023 - 01/2022
3	Diarrhea 11/2023 - 09/2017
3	Heart Failure 09/2023 - 10/2013
3	Acute Coronary Syndrome 01/2022 - 10/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 10/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 01/2022
2	Osteoporosis 03/2024 - 01/2023
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 02/2024 - 01/2022
2	Knee Osteoarthritis 01/2024 - 11/2023
2	Leukopenia 12/2023 - 09/2017
2	Experimental Arthritis 11/2023 - 12/2022
2	Rheumatoid Arthritis 11/2023 - 12/2022
2	Pathologic Complete Response 11/2023 - 09/2016
2	Reperfusion Injury 01/2023 - 01/2022
2	Brain Neoplasms (Brain Tumor) 07/2022 - 02/2021

Drug/Important Bio-Agent (IBA)

23	Hormones (Hormone)IBA 08/2023 - 01/2011
17	AnthracyclinesIBA 01/2022 - 01/2010
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2012
12	Capecitabine (Xeloda)FDA Link 12/2023 - 01/2010
12	human ERBB2 proteinIBA 01/2023 - 09/2012
10	Taxoids (Taxanes)IBA 03/2021 - 01/2010
8	Trastuzumab (Herceptin)FDA Link 11/2023 - 05/2014
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2012
8	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 09/2012
8	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023 - 01/2010
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2017
7	ErbB Receptors (EGF Receptor)IBA 11/2023 - 09/2017
7	Aromatase InhibitorsIBA 01/2023 - 01/2011
7	PlatinumIBA 01/2022 - 10/2014
6	Indicators and Reagents (Reagents)IBA 09/2023 - 11/2016
6	Fulvestrant (Faslodex)FDA Link 08/2023 - 01/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 09/2012
5	Peptides (Polypeptides)IBA 05/2024 - 01/2017
5	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2013
5	pyrotinibIBA 12/2023 - 09/2017
5	Estrogen ReceptorsIBA 07/2022 - 01/2013
5	CytokinesIBA 02/2022 - 01/2011
5	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 09/2016
5	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 01/2013
5	taxaneIBA 01/2018 - 08/2010
4	Phosphotransferases (Kinase)IBA 12/2023 - 01/2018
4	Tyrosine Kinase InhibitorsIBA 11/2023 - 09/2017
4	Phenobarbital (Luminal)FDA Link 02/2022 - 09/2014
3	CarbonIBA 03/2024 - 03/2023
3	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2015
3	TOR Serine-Threonine KinasesIBA 12/2023 - 10/2021
3	Everolimus FDA Link 12/2023 - 10/2021
3	Immune Checkpoint InhibitorsIBA 11/2023 - 09/2021
3	anlotinibIBA 11/2023 - 03/2021
3	exemestane (Aromasin)FDA Link 08/2023 - 07/2015
3	MTOR InhibitorsIBA 08/2023 - 12/2020
3	Sevoflurane (Ultane)FDA LinkGeneric 05/2023 - 01/2022
3	Epidermal Growth Factor (EGF)IBA 01/2023 - 10/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
3	apatinibIBA 05/2021 - 06/2019
3	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 01/2015
3	Tamoxifen FDA LinkGeneric 01/2019 - 01/2018
2	Neoplasm Antigens (Tumor Antigens)IBA 05/2024 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 12/2023
2	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2020
2	CateninsIBA 03/2024 - 11/2023
2	Sirtuin 1IBA 02/2024 - 12/2022
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2023 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023 - 01/2018
2	VaccinesIBA 11/2023 - 01/2022
2	Circulating Tumor DNAIBA 11/2023 - 09/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2023 - 12/2022
2	er-miao-sanIBA 11/2023 - 12/2022
2	Messenger RNA (mRNA)IBA 11/2023 - 11/2022
2	AntioxidantsIBA 10/2023 - 01/2020
2	Histone Deacetylase InhibitorsIBA 08/2023 - 01/2022
2	Glutathione (Reduced Glutathione)IBA 08/2023 - 01/2019
2	NucleotidesIBA 07/2023 - 01/2018
2	ZincIBA 05/2023 - 01/2017
2	CarbohydratesIBA 03/2023 - 03/2019
2	EnzymesIBA 03/2023 - 01/2022
2	Adenosine Monophosphate (AMP)IBA 01/2023 - 01/2019
2	LigandsIBA 01/2023 - 01/2021
2	Vitamin D FDA LinkGeneric 11/2022 - 01/2021

Therapy/Procedure

48	Therapeutics 05/2024 - 01/2010
30	Drug Therapy (Chemotherapy) 05/2024 - 09/2012
10	Neoadjuvant Therapy 01/2023 - 09/2012
9	Adjuvant Chemotherapy 01/2023 - 01/2018
6	Immunotherapy 11/2023 - 09/2021